CannaMD

DECEMBER 16, 2020

By joining, you will contribute to research that will help the consortium learn more about medical marijuana and improve the usefulness and safety for people who are using or considering using medical marijuana, just like yourself. Click the links below to browse condition-specific studies: ADHD. CannaMD ‘s got you covered!

Marijuana 119

Marijuana Epilepsy Treatment Safety 119

Project CBD

FEBRUARY 28, 2023

5 In June 2018, the FDA approved Epidiolex® (GW Pharmaceuticals; Cambridge, UK), the first FDA-approved pharmaceutical drug to contain a “purified drug substance [CBD] derived from marijuana,” for the treatment of seizures associated with two rare epilepsy disorders. Available at: www.fda.gov/media/131878/download. Epilepsy Behav.

CBD 144

CBD Seed-To-Sale Food Access 144

Healer

FEBRUARY 11, 2022

The two most important may be the suppression of tumor necrosis factor α release, a major contributor to inflammatory conditions, and stimulation of PPARγ, a nuclear receptor that controls the expression of genes involved in inflammation and metabolism. How much THCA should a person use? Has THCA been studied in humans? The post What is THCA?

Tincture 52

Tincture THC Epilepsy Cannabinoids 52

Cannabis Law Report

NOVEMBER 24, 2019

Severe treatment-resistant epilepsy. 1.4 Severe treatment-resistant epilepsy. NICE has made research recommendations on the use of cannabis-based medicinal products for severe treatment-resistant epilepsy. They should also have a special interest in the condition being treated [ 5 ]. Recommendations for research.

Medicine 59

Medicine Chronic Pain Research and Development Treatment 59

Cannabis Law Report

NOVEMBER 24, 2021

Medicinal cannabis has been legalised for use for a range of specified medical conditions in Australia since 2016. However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access.

Research and Development 52

Research and Development Medicine Access Media 52

Cannabis Law Report

JULY 15, 2022

Different strains for different conditions. Different strains are grown to treat different medical conditions. The schedule eight pharmaceutical medicine has gained federal approval to treat conditions including cancer-related pain, nausea and vomiting, multiple sclerosis and epilepsy, and for use in palliative care.

Medicine 52

Medicine Patients Media Supply Chain 52